Daily Diary Card (Geddes)

Name of Questionnaire

Daily Diary Card (Geddes)

Description

Chemotherapy-focused instrument designed for use in small cell lung cancer. Patients answer questions about their symptoms and general state daily. Usually used with a more detailed quality of life questionnaire (such as the Rotterdam Symptom Checklist or the European Organization for Research and Treatment of Cancer instruments) administered less frequently. Based on daily diary card designed by UK Medical Research Council.

Developer

DM Geddes, L Dones, E Hill, K Law, PG Harper, SG Spiro, JS Tobias, RL Souhami

Address

Professor S. Spiro
London Lung Cancer Group
CRC & UCL Cancer Trials Office
Macdonald Buchanan Building
John Astor House
Foley Street
London W1P 8AN, UK

E-mail

n.gower@ucl.ac.uk

URL

Not available.

Cost & availability

No charge. Contact London Lung Cancer Group for information

Administration

Self

Time to complete

Not reported

Number of items

8

Domains & categories

3

Name of categories/domains

Treatment-related symptoms, disease-related symptoms, general assessment

Scaling of items

4-point categorized scale for each question

Scoring

Not reported.

Reliability

Validity

Correlated as expected with nurse-completed Daily Diary Card (Geddes), EORTC QLQ-C30, and Spitzer quality of life index¹.

Responsiveness

Reported¹

Minimally important difference

Not reported.

Research use

Reported - oral etoposide treatment for advanced small cell lung cancer², low-dose/high frequency chemotherapy as palliative treatment of poor-prognosis small cell lung cancer³, weekly dose-intensive chemotherapy regimen compared with a³ weekly conventional treatment in good prognosis small cell lung cancer patients⁴, planned versus PRN chemotherapy in small cell lung cancer patients⁵

Clinical use

Not reported.

Language

English

References

1. Geddes DM, Dones L, Hill E, et al. Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. Eur J Cancer 1990; 26:484-92.
2. Souhami RL, Spiro SG, Rudd RM, et al. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst 1997; 89:577-80.
3. James LE, Gower NH, Rudd RM, et al. A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer Research Campaign trial. Br J Cancer 1996; 73:1563-8.
4. Gower NH, Rudd RM, Ruiz de Elvira MC, et al. Assessment of 'quality of life' using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer. Ann Oncol 1995; 6:575-80.
5. Earl HM, Rudd RM, Spiro SG, et al. A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer 1991; 64:566-72.

Date of information

May 1999